STING1 and cancer: Activation of the cGAS/STING pathway and production of immunomodulatory molecules such as INF-α, IL-6, CXCL9 and CXCL10 were described to be involved in the enhanced migration of immune cells in cancer, particularly macrophages, and regulate anti-tumor immune response (40,41).